Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Temporarily Not Available No phase listed Expanded access

Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)

ClinicalTrials.gov ID: NCT06033001

Public ClinicalTrials.gov record NCT06033001. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT06033001
Recruitment status
Temporarily Not Available
Study type
Expanded access
Phase
Not listed
Lead sponsor
Lantheus Medical Imaging
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • [Lu-177]-PNT2002 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jan 12, 2025

United States locations

U.S. sites
7
U.S. states
5
U.S. cities
7
Facility City State ZIP Site status
Hoag Memorial Hospital Presbyterian Newport Beach California 92663
Hartford HealthCare Cancer Institute at Hartford Hospital Hartford Connecticut 06106
Florida Theranostics Cancer Center Jupiter Florida 33458
Biogenix Molecular, LLC Miami Florida 33165
Comprehensive Hematology Oncology Trinity Florida 34655
BAMF Health, Inc Grand Rapids Michigan 49503
John Theurer Cancer Center at Hackensack Meridian University Medical Center Hackensack New Jersey 07601

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06033001, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 12, 2025 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06033001 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →